Publication | Closed Access

Therapy with imatinib mesylate (Glivec) preceding allogeneic stem cell transplantation (SCT) in relapsed or refractory Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL)

Hematological MalignancyCell TherapyTransplantationMarrow TransplantationOncologyMedicineMixed-phenotype Acute LeukemiaImmunologyHematologyStem CellsCell TransplantationImatinib MesylateHealth Sciences